or Try an Advanced Search...

    Technical Analysis for MNMD - Mind Medicine (MindMed) Inc.

    Grade Last Price % Change Price Change
    C 7.56 6.63% 0.47
    MNMD closed up 6.63 percent on Friday, November 22, 2024, on 89 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical MNMD trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    Crossed Above 200 DMA Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    Fell Below 20 DMA Bearish 6.63%
    Fell Below 200 DMA Bearish 6.63%
    Calm After Storm Range Contraction 6.63%
    Wide Bands Range Expansion 6.63%
    20 DMA Support Bullish 0.53%
    Crossed Above 200 DMA Bullish 0.53%
    Calm After Storm Range Contraction 0.53%
    Older End-of-Day Signals for MNMD ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 13 hours ago
    Rose Above 200 DMA about 13 hours ago
    60 Minute Opening Range Breakout about 16 hours ago
    200 DMA Resistance about 16 hours ago
    Up 5% about 16 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    MNMD Chart by TradingView
    Basic chart:

    Profile

    Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Drugs Drug Development Psychoactive Drugs Entheogens Psychedelic Drug N Dimethyltryptamine

    Is MNMD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer
    Nov 14 Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) market cap touched US$601m last week, benefiting both retail investors who own 41% as well as institutions
    Nov 13 MindMed to Participate in Upcoming Investor Conferences
    Nov 10 Mind Medicine: No News = Good News
    Nov 8 Mind Medicine (MindMed) Inc. (MNMD) Q3 2024 Earnings Call Transcript
    Nov 7 Mind Medicine (MindMed) Inc. 2024 Q3 - Results - Earnings Call Presentation
    Nov 7 Mind Medicine GAAP EPS of -$0.27 beats by $0.03
    Nov 7 MindMed Reports Third Quarter 2024 Financial Results and Business Updates
    Nov 6 Mind Medicine Q3 2024 Earnings Preview
    Nov 6 Massachusetts psychedelics legalization initiative poised to fail
    See more MNMD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.22
    52 Week Low 2.92
    Average Volume 1,146,860
    200-Day Moving Average 7.47
    50-Day Moving Average 6.44
    20-Day Moving Average 7.24
    10-Day Moving Average 7.79
    Average True Range 0.70
    RSI (14) 54.75
    ADX 30.03
    +DI 31.54
    -DI 18.48
    Chandelier Exit (Long, 3 ATRs) 7.76
    Chandelier Exit (Short, 3 ATRs) 7.96
    Upper Bollinger Bands 9.00
    Lower Bollinger Band 5.48
    Percent B (%b) 0.59
    BandWidth 48.69
    MACD Line 0.32
    MACD Signal Line 0.40
    MACD Histogram -0.0722
    Fundamentals Value
    Market Cap 303.12 Million
    Num Shares 40.1 Million
    EPS -1.87
    Price-to-Earnings (P/E) Ratio -4.04
    Price-to-Sales 0.00
    Price-to-Book 1.84
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 8.48
    Resistance 3 (R3) 8.41 8.03 8.32
    Resistance 2 (R2) 8.03 7.80 8.07 8.27
    Resistance 1 (R1) 7.80 7.66 7.92 7.87 8.22
    Pivot Point 7.42 7.42 7.48 7.46 7.42
    Support 1 (S1) 7.19 7.19 7.31 7.26 6.90
    Support 2 (S2) 6.81 7.05 6.85 6.85
    Support 3 (S3) 6.58 6.81 6.80
    Support 4 (S4) 6.65